Can the treatment of Helicobactor pylori decrease the incidence and severity of lesions with carcinogenic potential in patients with gastric carcinogenesis? Laboratory Investigation
Trastuzumab may significantly improve survival among women with advanced breast cancer, but there are concerns about cardiotoxicity associated with this targeted therapy. The current analysis examines this issue and means to prevent cardiac events among women receiving trastuzumab. Nature Clinical Practice Oncology
The procedure offers an option for patients who cannot undergo surgery but is also being chosen by patients as an alternative to surgery. Medscape Medical News
The use of tumor markers in testis cancer is low and varies considerably in the United States, despite the role markers can play in providing information pertinent to diagnosis, risk stratification, response to therapy, and disease recurrence. Medscape Medical News
Dr. Mark Pegram discusses the use of surrogate markers, dose selection, and other issues that arose in the wake of a recent drug approval for metastatic breast cancer. Medscape Hematology-Oncology
Despite increased perioperative complications, laparoscopic cryotherapy was safe and feasible for tumors larger than 3 cm, with no increased risk for bleeding, according to a European multicenter prospective trial. Medscape Medical News
Consolidation treatment with radioactive yttrium-90 ibritumomab tiuxetan is feasible, well tolerated, and effective in untreated patients with follicular non-Hodgkin lymphoma. Medscape Medical News
